InChI=1S/C19H27NO7S/c20- 14(19(26) 27) 13- 28- 16(15(21) 9- 8- 12- 18(24) 25) 10- 6- 4- 2- 1- 3- 5- 7- 11- 17(22) 23/h1- 7,10,14- 16,21H,8- 9,11- 13,20H2,(H,22,23) (H,24,25) (H,26,27) /b3- 1- ,4- 2+,7- 5?,10- 6+/t14- ,15- ,16+/m0/s1 |
MAFGRSDWXFSHMK-GHPSTRGMSA-N |
[H]C(CC(O)=O)=C\C=C/C=C/C=C/[C@@H](SC[C@H](N)C(O)=O)[C@@H](O)CCCC(O)=O |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
|
|
View more via ChEBI Ontology
Outgoing
|
16- carboxy- Δ13- 17,18,19,20- tetranor- leukotriene E4
(CHEBI:74016)
has functional parent
leukotriene E4
(CHEBI:15650)
16- carboxy- Δ13- 17,18,19,20- tetranor- leukotriene E4
(CHEBI:74016)
has role
metabolite
(CHEBI:25212)
16- carboxy- Δ13- 17,18,19,20- tetranor- leukotriene E4
(CHEBI:74016)
is a
L-cysteine thioether
(CHEBI:27532)
16- carboxy- Δ13- 17,18,19,20- tetranor- leukotriene E4
(CHEBI:74016)
is a
icosanoid
(CHEBI:23899)
16- carboxy- Δ13- 17,18,19,20- tetranor- leukotriene E4
(CHEBI:74016)
is a
non-proteinogenic L-α-amino acid
(CHEBI:83822)
16- carboxy- Δ13- 17,18,19,20- tetranor- leukotriene E4
(CHEBI:74016)
is a
secondary alcohol
(CHEBI:35681)
16- carboxy- Δ13- 17,18,19,20- tetranor- leukotriene E4
(CHEBI:74016)
is a
tricarboxylic acid
(CHEBI:27093)
|
|
Incoming
|
(13E)-16-carboxy-Δ13-17,18,19,20-tetranor-leukotriene E4
(CHEBI:74057)
is a
16- carboxy- Δ13- 17,18,19,20- tetranor- leukotriene E4
(CHEBI:74016)
|
(5Z,7E,9E,11R,12S)- 11- (L- cystein- S- yl)- 12- hydroxyhexadeca- 3,5,7,9- tetraenedioic acid
|
(5Z,7E,9E,11R,12S)- 11- {[(2R)- 2- amino- 2- carboxyethyl]sulfanyl}- 12- hydroxyhexadeca- 3,5,7,9- tetraenedioic acid
|
16-carboxy-Δ13-17,18,19,20-tetranor-LTE4
|
ChEBI
|
16-carboxy-Δ13-17,18,19,20-tetranor-LTE4
|
ChEBI
|
Δ13-16-carboxy-tetranor-LTE4
|
ChEBI
|
2174886
|
PubMed citation
|
Europe PMC
|
|